chartexchange

TNGX
Tango Therapeutics, Inc.
stockNASDAQ

At CloseNov 18, 2026 3:59:57 PM EST
21.87USD-1.085%(-0.24)2,746,148
Pre-marketNov 18, 2026 9:15:30 AM EST
22.36USD+1.131%(+0.25)
After-hoursNov 18, 2026 4:00:30 PM EST
21.89USD+0.091%(+0.02)
Loading…
Loading…
Healthcare
Biotechnology
HQ
Boston, MA, USA
Previous Close
$22.11
Beta
1.67
52-Week High
$34.39 2026-06-17
52-Week Low
$7.83 2025-11-19
SMA 50
$23.51
SMA 200
$23.06
Avg. Vol 10D
2.91M
Avg. Vol 30D
4.03M
Avg. Vol 90D
3.09M
Relative Vol
0.68
169.46M
121.52M
48,239,154
0.3900%
1,000,000
482,040
Mar 4, 2027 (105d)
TNGX Profile

tango therapeutics is a biotechnology company discovering and developing novel medicines targeting cancer vulnerabilities to deliver transformational new therapies for patients. tango was launched in 2017 with a $55 million series a investment from third rock ventures. the company has established a robust product engine that leverages advances in dna sequencing and crispr-based target discovery to generate breakthrough medicines that have the potential to provide deeper, more sustained benefit than today's targeted therapies, and extend the benefit of available immuno-oncology agents. tango therapeutics is focused on three areas of drug development, each in well-defined patient populations currently lacking effective treatment options, and each with hallmarks of cancer that have not been targeted yet. these include: loss of tumor suppressor gene function; multiple oncogenic drivers; and immune evasion. what fuels each of tango's programs is an increasingly sophisticated ability to util

TNGX Performance
PeriodPriceDateChangeBeta
1W24.852026-11-12-11.91%4.221
1M23.532026-10-19-6.97%2.280
3M25.202026-08-19-13.13%2.064
6M20.302026-05-19+7.83%2.215
1Y8.292025-11-19+164.21%1.673
2Y3.852024-11-19+468.57%—
5Y11.972021-11-19+82.87%1.345
TNGX Stock Summary

Tango Therapeutics, Inc. (NASDAQ:TNGX) stock price today is $21.89, and today's volume is 2,746,148. TNGX is down 0.995% today. The 30 day average volume is 4.03M. TNGX market cap is $3.71B with 169.46M shares outstanding.